Actualités Cytori Therapeutics Inc - CYTX | Actions NASDAQ

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Curren...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Curren...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under...

Statement of Ownership (sc 13g)

SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE...

Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)

Filed Pursuant to Rule 424(b)(4) Registration No. 333-229485 PROSPECTUS ...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESS...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Curren...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Curren...

Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)

Issuer Free Writing Prospectus dated September 16, 2019 Filed pursuant to Rule 433 under the Securities Act of...

Securities Registration Statement (s-1/a)

As filed with the Securities and Exchange Commission on September 16, 2019 Registration No. 333-229485 UN...

Securities Registration Statement (s-1/a)

As filed with the Securities and Exchange Commission on September 10, 2019 Registration No. 333-229485 ...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Curren...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cytori Therapeutics Inc (CYTX)

Outils de qualité professionnelle, pour des investisseurs individuels.

CYTX Actualités

Current Report Filing (8-k)

Current Report Filing (8-k)

Statement of Ownership (sc 13g)

Statement of Ownership (sc 13g)

Statement of Ownership (sc 13g)

Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)

Notice of Effectiveness (effect)

Current Report Filing (8-k)

Current Report Filing (8-k)

Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)

Securities Registration Statement (s-1/a)

Securities Registration Statement (s-1/a)

Current Report Filing (8-k)

Statement of Ownership (sc 13g)

Current Report Filing (8-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cytori Therapeutics Inc (CYTX) Actualités

Cytori Therapeutics Inc (CYTX)

Outils de qualité professionnelle, pour des investisseurs individuels.

CYTX Actualités

Current Report Filing (8-k)

Current Report Filing (8-k)

Statement of Ownership (sc 13g)

Statement of Ownership (sc 13g)

Statement of Ownership (sc 13g)

Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)

Notice of Effectiveness (effect)

Current Report Filing (8-k)

Current Report Filing (8-k)

Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)

Securities Registration Statement (s-1/a)

Securities Registration Statement (s-1/a)

Current Report Filing (8-k)

Statement of Ownership (sc 13g)

Current Report Filing (8-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application